What Does 25 Units of Semaglutide Actually Refer To?

Why do people talk about 25 units of semaglutide at all?

The phrase originates from the world of compounded peptide preparations, most commonly sold online, where semaglutide is supplied as a lyophilised powder or liquid in a small vial. To administer a dose from a vial you need a syringe, and insulin syringes measure in units rather than milligrams. Depending on how a vial is reconstituted (how much bacteriostatic water is added) the concentration changes, and so does the number of units needed to equal a target dose in milligrams. Twenty-five units from one batch could be a completely different amount of active drug to 25 units from another.

This variability is precisely why the UK's licensed weight-loss medicines don't work this way. The Wegovy pre-filled pen holds a fixed concentration; the mechanism delivers the stated dose automatically. There's nothing to calculate, nothing to measure and nothing to get wrong. If you want to understand how semaglutide doses translate across different measurement systems, our guide to semaglutide ml to units conversions unpacks the maths, though for licensed UK treatment, that conversion is simply not something patients need to do.

A quick check you can do right now: look up any semaglutide product on the GPhC pharmacy register. If the seller isn't listed, the product isn't coming from a registered UK pharmacy, and that's a meaningful red flag before you go any further.

What do the licensed semaglutide doses in the UK actually look like?

In the UK, semaglutide for weight management is licensed as Wegovy. The dose ladder runs from 0.25 mg up to 2.4 mg weekly by injection, or (as of June 2026) from 1.5 mg up to 25 mg daily as the new Wegovy tablet. Yes, the oral version does use a 25 mg figure, but that's 25 milligrams, a maintenance tablet dose taken once a day in very specific conditions, and it's a completely separate product from anything measured in syringe units.

The injection pathway was recently extended: the MHRA approved a 7.2 mg single-dose pen in April 2026, giving prescribers a higher-dose option for adults who've plateaued on 2.4 mg. The NHS England page on weight management injections describes how licensed treatment is structured for UK patients.

None of these licensed presentations involve drawing semaglutide from a vial. The dose is pre-set. That consistency is a feature of the regulatory process, not a coincidence. It removes dosing error from the equation and gives prescribers a predictable pharmacokinetic profile to work with when they're titrating someone's treatment.

If you're trying to make sense of lower doses in the titration sequence, the context around 5 units of semaglutide and 10 units of semaglutide follows the same logic, those figures appear online in unlicensed vial contexts, not in the licensed pen schedule.

Is unlicensed vial semaglutide legal or safe to use in the UK?

This is where clarity really matters. The MHRA has not approved compounded semaglutide vials for weight management in the UK. Products described using unit-based dosing are not part of the licensed supply chain. They're typically sold online, sometimes without any clinical assessment, and the MHRA has repeatedly warned the public about counterfeit and substandard injectable weight-loss products circulating through social media and unregistered sellers.

Beyond legitimacy, there's a practical safety concern: reconstituting a peptide from powder, calculating how many syringe units equate to a clinical dose, and self-administering without trained support introduces real risk of error. An overdose from a miscalculated vial preparation is a genuine medical emergency. An underdose means someone is taking on the risks of treatment without any meaningful benefit.

For anyone who's seen the semaglutide vials or bottles being discussed online, the short answer is that they exist in a legal and clinical grey zone that the licensed products simply don't occupy. The semaglutide overview on this site goes into more detail on what's actually available through regulated UK channels.

What should someone do if they want licensed semaglutide for weight management?

The legal route is a prescription, issued by a qualified prescriber after a proper clinical assessment. That assessment covers BMI, any weight-related conditions, your medical history and any medicines you're already taking. Semaglutide isn't suitable for everyone, and a prescriber's job is to work that out before treatment starts, not after.

For those exploring weight-loss treatment options more broadly, it's also worth knowing that tirzepatide (Mounjaro) is the other licensed injectable for weight management in the UK, a different mechanism, different trial evidence, and a conversation worth having with a clinician. Cost is a real consideration too; the cost context around Wegovy helps frame what a legitimate private prescription typically involves.

If you'd like to find out whether Wegovy is appropriate for you, nume's prescribers review consultations the same day and can talk you through your options. There's no obligation and the consultation is free.